Search Results - "Morgan, Esi M"

Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors by Schulert, Grant S., Yasin, Shima, Carey, Brenna, Chalk, Claudia, Do, Thuy, Schapiro, Andrew H., Husami, Ammar, Watts, Allen, Brunner, Hermine I., Huggins, Jennifer, Mellins, Elizabeth D., Morgan, Esi M., Ting, Tracy, Trapnell, Bruce C., Wikenheiser‐Brokamp, Kathryn A., Towe, Christopher, Grom, Alexei A.

“…Objective Systemic juvenile idiopathic arthritis (JIA) is associated with a recently recognized, albeit poorly defined and characterized, lung disease (LD)…”
Get full text

Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches by Gmuca, Sabrina, Xiao, Rui, Brandon, Timothy G, Pagnini, Ilaria, Wright, Tracey B, Beukelman, Timothy, Morgan, Esi M, Weiss, Pamela F

“…Enthesitis-related arthritis (ERA) is a specific subtype of juvenile idiopathic arthritis (JIA) defined according to the International League of Associations…”
Get full text

A PROMIS Measure of Neuropathic Pain Quality by Askew, Robert L., PhD, MPH, Cook, Karon F., PhD, Keefe, Francis J., PhD, Nowinski, Cindy J., MD, PhD, Cella, David, PhD, Revicki, Dennis A., PhD, Morgan DeWitt, Esi M., MD, Michaud, Kaleb, PhD, Trence, Dace L., MD, Amtmann, Dagmar, PhD

“…Abstract Objectives Neuropathic pain (NP) is a consequence of many chronic conditions. This study aimed to develop an unidimensional NP scale with scores that…”
Get full text

Hospitalised infections and rituximab administration among children and adolescents with systemic lupus erythematosus from 2009 to 2021 by Roberts, Jordan E, Faino, Anna V, Bryan, Mersine A, Cogen, Jonathan D, Morgan, Esi M

“…BackgroundRituximab is associated with high infection rates, but studies of infections following rituximab in youth with childhood-onset SLE (cSLE) are…”
Get full text

Digital health technology to support patient-centered shared decision making at point of care for juvenile idiopathic arthritis by Huang, Bin, Kouril, Michal, Chen, Chen, Daraiseh, Nancy M., Ferraro, Kerry, Mannion, Melissa L., Brunner, Hermine I., Lovell, Daniel J., Morgan, Esi M.

“…Despite availability of multiple FDA approved therapies, many children with juvenile idiopathic arthritis (JIA) suffer pain and disability due to uncontrolled…”
Get full text

Assessing disparities through missing race and ethnicity data: results from a juvenile arthritis registry by Banschbach, Katelyn M, Singleton, Jade, Wang, Xing, Vora, Sheetal S, Harris, Julia G, Lytch, Ashley, Pan, Nancy, Klauss, Julia, Fair, Danielle, Hammelev, Erin, Gilbert, Mileka, Kreese, Connor, Machado, Ashley, Tarczy-Hornoch, Peter, Morgan, Esi M

“…Ensuring high-quality race and ethnicity data within the electronic health record (EHR) and across linked systems, such as patient registries, is necessary to…”
Get full text

Exploring Pediatric Tele-Rheumatology Practices During COVID-19: A Survey of the PRCOIN Network by Goh, Y Ingrid, Bullock, Danielle R, Taylor, Janalee, Pooni, Rajdeep, Lee, Tzielan C, Vora, Sheetal S, Yildirim-Toruner, Cagri, Morgan, Esi M, Pan, Nancy, Harris, Julia G, Warmin, Andrew, Wiegand, Kendra, Burnham, Jon M, Barbar-Smiley, Fatima

“…Healthcare providers were rapidly forced to modify the way they practiced medicine during the coronavirus disease 2019 (COVID-19) pandemic. Many providers…”
Get full text

Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network by Harris, Julia G, Bingham, Catherine A, Vora, Sheetal S, Yildirim-Toruner, Cagri, Batthish, Michelle, Bullock, Danielle R, Burnham, Jon M, Fair, Danielle C, Ferraro, Kerry, Ganguli, Suhas, Gilbert, Mileka, Gottlieb, Beth S, Halyabar, Olha, Hazen, Melissa M, Laxer, Ronald M, Lee, Tzielan C, Liu, Alice, Lovell, Daniel J, Mannion, Melissa L, Oberle, Edward J, Pan, Nancy, Shishov, Michael, Weiss, Jennifer E, Morgan, Esi M

“…The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a North American learning health network focused on improving outcomes of…”
Get full text

Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis by Huang, Bin, Qiu, Tingting, Chen, Chen, Zhang, Yin, Seid, Michael, Lovell, Dan, Brunner, Hermine I, Morgan, Esi M, Adams, Michelle, Beukelman, Timothy, Kocsis, Anne, Kohlheim, Melanie, Guo, Jeff, Gray, Stephanie, Liu, Jinzhong, Neace, Alivia, Sivaganisan, Siva, Woeste, Stacey, Yue, Xiaomeng, Zahner, Janet

“…ObjectivesTo compare real-world effectiveness of two adaptive treatment strategies of disease-modifying antirheumatic drugs (DMARDs) in treating children with…”
Get full text

Treating juvenile idiopathic arthritis to target: recommendations of an international task force by Ravelli, Angelo, Consolaro, Alessandro, Horneff, Gerd, Laxer, Ronald M, Lovell, Daniel J, Wulffraat, Nico M, Akikusa, Jonathan D, Al-Mayouf, Sulaiman M, Antón, Jordi, Avcin, Tadej, Berard, Roberta A, Beresford, Michael W, Burgos-Vargas, Ruben, Cimaz, Rolando, De Benedetti, Fabrizio, Demirkaya, Erkan, Foell, Dirk, Itoh, Yasuhiko, Lahdenne, Pekka, Morgan, Esi M, Quartier, Pierre, Ruperto, Nicolino, Russo, Ricardo, Saad-Magalhães, Claudia, Sawhney, Sujata, Scott, Christiaan, Shenoi, Susan, Swart, Joost F, Uziel, Yosef, Vastert, Sebastiaan J, Smolen, Josef S

“…Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an achievable goal for most patients. Reaching this target leads to…”
Get more information

Hospitalization and Mortality Due to Infection Among Children and Adolescents With Systemic Lupus Erythematosus in the United States by Roberts, Jordan E, Faino, Anna, Bryan, Mersine A, Cogen, Jonathan D, Morgan, Esi M

“…We aimed to determine the frequency and types of infections in hospitalized children with childhood-onset systemic lupus erythematosus (cSLE), and to identify…”
Get full text

Measures of Health Status and Quality of Life in Juvenile Idiopathic Arthritis by Morgan, Esi M., Carle, Adam C.

Get full text

Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus by Tarkiainen, Maarit, Balay-Dustrude, Erin, Consolaro, Alessandro, Morgan, Esi M, Ruperto, Nicolino, Rypdal, Veronika, Backström, Maria, Vähäsalo, Paula, Gottlieb, Beth S

“…The physician global assessment of disease activity (PhGA) is a tool used nearly ubiquitously by pediatric rheumatologists for the assessment of patient…”
Get full text

Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers by Morgan, Esi M., Mara, Constance A., Huang, Bin, Barnett, Kimberly, Carle, Adam C., Farrell, Jennifer E., Cook, Karon F.

“…Background Patient-Reported Outcomes Measurement Information System (PROMIS) measures are used increasingly in clinical care. However, for juvenile idiopathic…”
Get full text

Development and evaluation of the patient-reported outcomes measurement information system (PROMIS) pediatric pain quality item bank and short form by Mara, Constance A., Carle, Adam C., Goldschneider, Kenneth R., Kashikar-Zuck, Susmita, Sherry, David D., Dampier, Carlton, Morgan, Esi M.

“…Pain is a common problem among children, particularly those with pediatric chronic diseases. Multifaceted assessment of pain can improve communication about…”
Get full text

Development and validation of the self-reported PROMIS pediatric pain behavior item bank and short form scale by Cunningham, Natoshia R., Kashikar-Zuck, Susmita, Mara, Constance, Goldschneider, Kenneth R., Revicki, Dennis A., Dampier, Carlton, Sherry, David D., Crosby, Lori, Carle, Adam, Cook, Karon F., Morgan, Esi M.

“…Pain behaviors are important indicators of functioning in chronic pain; however, no self-reported pain behavior instrument has been developed for pediatric…”
Get full text

Rheumatology Informatics System for Effectiveness: A National Informatics‐Enabled Registry for Quality Improvement by Yazdany, Jinoos, Bansback, Nick, Clowse, Megan, Collier, Deborah, Law, Karen, Liao, Katherine P., Michaud, Kaleb, Morgan, Esi M., Oates, James C., Orozco, Catalina, Reimold, Andreas, Simard, Julia F., Myslinski, Rachel, Kazi, Salahuddin

“…Objective The Rheumatology Informatics System for Effectiveness (RISE) is a national electronic health record (EHR)–enabled registry. RISE passively collects…”
Get full text

Quality of Care in Childhood-onset Systemic Lupus Erythematosus: Report of an Intervention to Improve Cardiovascular and Bone Health Screening by Smitherman, Emily A, Huang, Bin, Furnier, Adam, Taylor, Janalee, Burns, Mary Beth, Brunner, Hermine I, Morgan, Esi M

“…Initial benchmarking of childhood-onset systemic lupus erythematosus (cSLE) quality indicators revealed suboptimal performance across multiple centers. Our aim…”
Get full text

Improving care delivery and outcomes in pediatric rheumatic diseases by Harris, Julia G, Bingham, Catherine A, Morgan, Esi M

“…PURPOSE OF REVIEWThis article highlights efforts in pediatric rheumatology related to optimizing the care provided to patients with pediatric rheumatic…”
Get full text

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases by Ringold, Sarah, Nigrovic, Peter A, Feldman, Brian M, Tomlinson, George A, von Scheven, Emily, Wallace, Carol A, Huber, Adam M, Schanberg, Laura E, Li, Suzanne C, Weiss, Pamela F, Fuhlbrigge, Robert C, Morgan, Esi M, Kimura, Yukiko

“…The pediatric rheumatic diseases are a heterogeneous group of rare diseases, posing a number of challenges for the use of traditional clinical and…”
Get full text